Linagliptin Export Market Intelligence: India's 118 Suppliers Shipping to 61 Countries — TransData Nexus 2026

Q: Who are the top linagliptin exporters from India?

The top linagliptin exporters from India are: 1. BETA DRUGS LIMITED — $2.5M (65.1% market share); 2. GANPATI EXIM INC — $135.6K (3.5% market share); 3. SHREE SSD PHARMA PRIVATE LIMITED — $127.6K (3.3% market share); 4. BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED — $90.5K (2.3% market share); 5. DELTA BIOPHARMA PRIVATE LIMITED — $80.5K (2.1% market share). Together they account for 76.3% of India's total linagliptin export value.

Q: What is the total export value of linagliptin from India?

The total export value of linagliptin from India is $3.9M USD, recorded across 1,375 shipment transactions from 118 active exporters to 61 destination countries. The average shipment value is $2.8K.

Q: Which countries import linagliptin from India?

India exports linagliptin to 61 countries worldwide. The top importing countries are: MEXICO (66.2% share, $2.6M), SINGAPORE (7.2% share, $279.3K), MAURITIUS (3.8% share, $149.6K), SRI LANKA (2.6% share, $102.0K), SAUDI ARABIA (2.4% share, $93.7K). These five markets account for 82.3% of total export value.

Q: What is the HS code for linagliptin exports from India?

The primary HS code for linagliptin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of linagliptin exports from India?

The average unit price for linagliptin exports from India is $27.17 USD per unit, with prices ranging from $0.01 to $2385.65 depending on formulation, packaging, and order volume. The total market is valued at $3.9M across 1,375 shipments.

Q: Which ports handle linagliptin exports from India?

The primary ports for linagliptin exports from India are DELHI AIR CARGO ACC (INDEL4) (27.7% of shipments), DELHI AIR (19.3% of shipments), SAHAR AIR (10.8% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.9% of shipments), Delhi Air Cargo (6.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of linagliptin?

India is one of the world's leading exporters of linagliptin due to its large base of 118 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports linagliptin to 61 countries, demonstrating 31% global market coverage.

Q: What certifications do Indian linagliptin exporters need?

Indian linagliptin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import linagliptin from India?

There are 163 registered buyers importing linagliptin from India, spread across 61 countries. The repeat buyer rate is 62.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top linagliptin supplier from India?

BETA DRUGS LIMITED is the leading linagliptin exporter from India with a market share of 65.1% and total export value of $2.5M across 124 shipments. The top 5 suppliers together control 76.3% of total export value.

Suresh Sormare

Linagliptin

India Pharmaceutical Trade Intelligence

$3.9M118 Suppliers61 CountriesHS 30049099

ExportsIndia → MEXICO66.2%India → SINGAPORE7.2%

ImportsGERMANY → India$14.7B GREECE → India$51.6K

#1 Supplier: BETA DRUGS

Linagliptin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Linagliptin to the World

Between 2022 and 2026, India exported $3.9M worth of linagliptin across 1,375 verified shipments to 61 countries — covering 31% of world markets in the Advanced Diabetes Medications segment. The largest destination is MEXICO (66.2%). BETA DRUGS LIMITED leads with a 65.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Linagliptin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Linagliptin export data snapshot — $3.9M · 118 exporters · 61 countriesTransData Nexus · Indian Customs Data

Top Linagliptin Exporters from India

118 active exporters · Ranked by export value

View all 118 →

Top Linagliptin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	BETA DRUGS LIMITED	$2.5M	124	1	65.1%
2	GANPATI EXIM INC

Top Countries Importing Linagliptin from India

61 destination markets · Ranked by import value

All 61 countries →

Top Countries Importing Linagliptin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	MEXICO	$2.6M	66.2%
2	SINGAPORE	$279.3K	7.2%
3	MAURITIUS	$149.6K	3.8%
4	SRI LANKA	$102.0K	2.6%
5	SAUDI ARABIA	$93.7K	2.4%
6	KENYA	$79.3K	2.0%
7	UNITED ARAB EMIRATES	$70.1K	1.8%
8	AZERBAIJAN	$62.4K	1.6%
9	BELGIUM	$59.2K	1.5%
10	GUATEMALA	$53.4K	1.4%

MEXICO is India's largest linagliptin export destination, absorbing 66.2% of total exports worth $2.6M. The top 5 importing countries — MEXICO, SINGAPORE, MAURITIUS, SRI LANKA, SAUDI ARABIA — together account for 82.3% of India's total linagliptin export value. The remaining 56 destination countries collectively receive the other 17.7%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Linagliptin to India?

29 origin countries · Total import value: $14.8B

India imports linagliptin from 29 countries with a combined import value of $14.8B. The largest supplier is GERMANY ($14.7B, 156 shipments), followed by UNITED STATES and GREECE. All values are from Indian Customs (DGFT) import records.

Countries Supplying Linagliptin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$14.7B	156	99.6%
2	UNITED STATES	$59.3M	100	0.4%
3	GREECE	$51.6K	16	0.0%
4	AUSTRALIA	$51.4K	8	0.0%
5	ISRAEL	$35.9K	20	0.0%
6	BRAZIL	$24.5K	23	0.0%
7	NETHERLANDS	$12.7K	10	0.0%
8	BELGIUM	$9.5K	5	0.0%
9	CHINA	$9.1K	4	0.0%
10	UNITED KINGDOM	$8.5K	20	0.0%

Showing top 10 of 29 origin countries

GERMANY is the largest supplier of linagliptin to India, accounting for 99.6% of total import value. The top 5 origin countries — GERMANY, UNITED STATES, GREECE, AUSTRALIA, ISRAEL — together supply 100.0% of India's linagliptin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Linagliptin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for linagliptin, indicating a competitive generic market. Recent approvals include those granted in January 2026. No import alerts specific to linagliptin have been issued by the FDA, suggesting compliance with U.S. regulatory standards. The regulatory pathway for linagliptin involves submission of an ANDA, demonstrating bioequivalence to the reference listed drug. With 118 active Indian exporters and a repeat buyer rate of 62.6%, the U.S. market presents significant opportunities for Indian manufacturers.

2EU & UK Regulatory Framework

The European Medicines Agency (EMA) granted marketing authorization for linagliptin-containing products, such as Jentadueto, on 24 November 2016. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, ensuring consistent regulatory requirements across Europe. Compliance with EU Good Manufacturing Practice (GMP) guidelines is mandatory for market access.

3WHO Essential Medicines & Global Standards

Linagliptin is included in the 22nd edition of the WHO Model List of Essential Medicines, underscoring its importance in diabetes management. While not listed in the WHO Prequalification Programme, linagliptin must meet pharmacopoeial standards such as those outlined in the United States Pharmacopeia (USP) and the British Pharmacopoeia (BP) to ensure quality and efficacy.

4India Regulatory Classification

In India, linagliptin is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensation. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for linagliptin, allowing market-driven pricing. Export of linagliptin necessitates a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with export regulations.

5Patent & Exclusivity Status

The primary patent for linagliptin expired in 2022, leading to increased generic competition. This has resulted in a diversified market with multiple manufacturers offering generic versions, enhancing accessibility and affordability.

6Recent Industry Developments

In June 2025, the NPPA issued guidelines to streamline the approval process for generic drugs, potentially benefiting linagliptin manufacturers. In September 2025, the FDA approved a new generic version of linagliptin, further intensifying market competition. In December 2025, the EMA updated its guidelines on bioequivalence studies, impacting the approval process for generic linagliptin products. In February 2026, the WHO released a report emphasizing the need for stringent quality control in the production of antidiabetic medications, including linagliptin. In March 2026, the CDSCO announced a crackdown on substandard pharmaceutical exports, highlighting the importance of compliance for linagliptin exporters.

These developments reflect a dynamic regulatory environment, necessitating continuous monitoring by stakeholders involved in the export and distribution of linagliptin.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Linagliptin

Retail & reference prices across 9 markets vs. India FOB export price of $27.17/unit

Global Price Benchmark for Linagliptin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$28.38	USD	According to a 2023 analysis, the average daily cost of liraglutide, a GLP-1 receptor agonist, in the United States is $28.38. (cdn.who.int) While this data pertains to liraglutide, it provides a contextual benchmark for the pricing of similar antidiabetic medications.
United Kingdom	$4.29	GBP	The British National Formulary (BNF) lists the daily cost of liraglutide at $4.29 in the UK. (cdn.who.int) This figure serves as a reference point for the pricing of comparable antidiabetic agents.
Germany	Data not available	EUR	Specific pricing data for linagliptin in Germany is not readily accessible from the available sources.

Supply Chain Risk Assessment — Linagliptin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). Over 70% of APIs used by Indian manufacturers are imported, primarily from China. This dependency poses significant risks, as any disruption in Chinese supply chains can directly impact Indian pharmaceutical production. For instance, in 2022, lockdowns in Shanghai delayed shipments of oncology drug intermediates, leading to rationing of inventories by downstream manufacturers.

To mitigate such vulnerabilities, the Indian government introduced the Production Linked Incentive (PLI) scheme, aiming to bolster domestic API and KSM manufacturing. This initiative seeks to reduce reliance on imports by incentivizing local production through financial support and infrastructure development. (pharmanow.live)

2Supplier Concentration & Single-Source Risk

The Linagliptin export market from India exhibits a high degree of supplier concentration. The top five exporters account for 76.3% of the total export value, with BETA DRUGS LIMITED alone contributing 65.1%. Such concentration poses a single-source risk; any operational or financial issues within these key suppliers could disrupt the entire supply chain.

The PLI scheme is designed to address these risks by promoting diversification and encouraging more manufacturers to enter the API and KSM production space. By providing financial incentives and support, the scheme aims to reduce dependency on a limited number of suppliers and enhance the resilience of the pharmaceutical supply chain. (pharmanow.live)

Access Complete Linagliptin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,375 transactions across 61 markets.

Request Demo View Pricing

Frequently Asked Questions — Linagliptin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top linagliptin exporters from India?

The leading linagliptin exporters from India are BETA DRUGS LIMITED, GANPATI EXIM INC, SHREE SSD PHARMA PRIVATE LIMITED, and 7 others. BETA DRUGS LIMITED leads with 65.1% market share ($2.5M). The top 5 suppliers together control 76.3% of total export value.

What is the total export value of linagliptin from India?

The total export value of linagliptin from India is $3.9M, recorded across 1,375 shipments from 118 active exporters to 61 countries. The average shipment value is $2.8K.

Which countries import linagliptin from India?

India exports linagliptin to 61 countries. The top importing countries are MEXICO (66.2%), SINGAPORE (7.2%), MAURITIUS (3.8%), SRI LANKA (2.6%), SAUDI ARABIA (2.4%), which together account for 82.3% of total export value.

What is the HS code for linagliptin exports from India?

The primary HS code for linagliptin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Linagliptin

Linagliptin

Top Linagliptin Exporters from India

Top Countries Importing Linagliptin from India

Who Supplies Linagliptin to India?

Quick Facts

Related Advanced Diabetes Medications

Related Analysis

Need Details?

Regulatory Landscape — Linagliptin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Linagliptin

Supply Chain Risk Assessment — Linagliptin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Linagliptin Trade Intelligence

Frequently Asked Questions — Linagliptin Exports from India

Who are the top linagliptin exporters from India?

What is the total export value of linagliptin from India?

Which countries import linagliptin from India?

What is the HS code for linagliptin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of linagliptin exports from India?

Which ports handle linagliptin exports from India?

Why is India a leading exporter of linagliptin?

What certifications do Indian linagliptin exporters need?

How many buyers import linagliptin from India?

What is the market share of the top linagliptin exporter from India?

Analysis Methodology